De Novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines: Elevated class 1 ALDH activity is closely correlated with reduction in DNA interstrand cross-linking and lethality

Journal of Biological Chemistry

Volumn 271, Issue 20, 1996, Pages 11884-11890

  Bunting, Kevin D ^a,b   Townsend, Alan J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRICETINAE; CRICETULUS GRISEUS;

ACROLEIN; ALDEHYDE DEHYDROGENASE; IFOSFAMIDE; MELPHALAN; OXAZAPHOSPHORINE; PHOSPHORAMIDE MUSTARD;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CHO CELL; CROSS RESISTANCE; CYTOTOXICITY; DNA CROSS LINKING; DRUG RESISTANCE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; LETHALITY; NONHUMAN; PRIORITY JOURNAL;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BASE SEQUENCE; CELL LINE; CRICETINAE; CRICETULUS; CYCLOPHOSPHAMIDE; DNA; DRUG RESISTANCE; ENZYME INHIBITORS; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; PHOSPHORAMIDE MUSTARDS; TRANSFECTION;

EID: 0029888371     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.271.20.11884     Document Type: Article

References (41)

1. Lindahl, R., and Petereen, D. R. (1991) Biochem. Pharmacol. 41, 1583-1587
2. Lindahl, R. (1992) Crit. Rev. Biochem. Mol. Biol. 27, 283-335
3. Sladek, N. E., Manthey, C. L., P.A., M., Zhang, Z., and Landkamer, G. J. (1989) Drug Metab. Rev. 20, 697-720
4. Sladek, N. E. (1988) Pharmacol. Ther. 37, 301-355
5. Chang, T., Weber, G. F., Crespi, C. L., and Waxman, D. J. (1993) Cancer Res. 53, 5629-5637
6. Ruaso, J., Hilton, J., and Colvin, O. M. (eds) (1989), in Enzymology and Molecular Biology of Carbonyl Metabolism, Vol. 2, Alan R. Liss, Inc., New York
7. Colvin, O. M., and Chabner, B. (1990) in Cancer Chemotherapy: Principles and Practice, pp. 276-313, J. B. Lippincott, Philadelphia
8. Hill, D. L., Laster, W. R. J., and Struck, R. F. (1972) Cancer Res. 32, 658-665
9. Sladek, N. E., Dockham, P. A., and Lee, M. O. (1991) Adv. Exp. Med. Biol. 284, 97-104
10. Lee, M. O., Manthey, C. L., and Sladek, N. E. (1991) Biochem. Pharmacol. 42, 1279-1285
11. Dockham, P. A., Lee, M. O., and Sladek, N. E. (1992) Biochem. Pharmacol. 43, 2453-2469
12. Manthey, C. L., Landkamer, G. J., and Sladek, N. E. (1990) Cancer Res. 50, 4991-5002
13. Hilton, J. (1984) Cancer Res. 44, 5156-5160
14. Sreerama, L., and Sladek, N. E. (1993) Biochem. Pharmacol. 45, 2487-2505
15. Rekha, G. K., Sreerama, L., and Sladek, N. E. (1994) Biochem. Pharmacol. 48, 1943-1952
16. Zheng, C. F., Wang, T., and Weiner, H. (1993) Alcoholism 17, 828-831
17. DeJong, J. L., Chang, C.-M., Whang-Peng, J., Knutsen, T., and Tu, C.-P. D. (1988) Nucleic Acids Res. 16, 8541-8554
18. Townsend, A. J., Tu, C. P., and Cowan, K. H. (1992) Mol. Pharmacol. 41, 230-236
19. Kozak, M. (1994) Biochimie (Paris) 76, 815-821
20. Kano, T., Sakai, M., and Muramatsu, M. (1987) Cancer Res. 47, 5626-5630
21. Doehmer, J., Dogra, S., Friedberg, T., Monier, S., Adesnik, M., Glatt, H., and Oesch, F. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 5769-5773
22. German, C., Padmanabhan, R., and Howard, B. (1983) Science 221, 551-553
23. Manthey, C. L., and Sladek, N. E. (1988) Biochem. Pharmacal. 37, 2781-2790
24. Bunting, K. D., Lindahl, R., and Townsend, A. J. (1994) J. Biol. Chem. 269, 23197-23203
25. Cesarone, C. F., Bolognesi, C., and Santi, L. (1979) Anal. Biochem. 100, 188-197
26. Pasleau, F., Tocci, M., Leung, F., and Kopchick, J. (1985) Gene (Amst.) 38, 227-232
27. Niemeyer, U., Engel, J., Hilgard, P., Peukert, M., Pohl, J., and Sindermann, H. (1989) Prog. Clin. Biochem. Med. 9, 35-60
28. De, G. C., Martens, A., and Hagenbeek, A. (1994) Eur. J Cancer 30A, 2137-2143.
29. Kohn, F. R., and Sladek, N. E. (1985) Biochem. Pharmacol. 34, 3465-3471
30. Kastan, M. B., Schlaffer, E., Russo, J. E., Colvin, O. M., Civin, C. L, and Hilton, J. (1990) Blood 75, 1947-1950
31. Sreerama, L., and Sladek, N. E. (1993) Adv. Exp. Med. Biol. 328, 99-113
32. Sreerama, L., and Sladek, N. E. (1994) Cancer Res. 54, 2176-2185
33. Sreerama, L., Rekha, G. K, and Sladek, N. E. (1995) Biochem. Pharmacol. 49, 669-675
34. Brock, N., Habs, M., Pohl, J., Schmahl, J., and Stekar, J. (1982) Therapiewoche 32, 4975-4996
35. Cox, P. J. (1979) Biochem. Pharmacol. 28, 2045-2049
36. Mitchell, D. Y., and Petersen, D. R. (1988) Drug Metab. Dispos. 16, 37-42
37. Adams, J. J., and Klaidman, L. K. (1993) Free Radical Biol. Med. 15,187-193
38. Sladek, N., and Sreerama, L. (1995) Proc. Am. Assoc. Cancer Res. 35, 325
39. Moreb, J., Zucali, J. R., Zhang, Y., Colvin, M. O., and Gross, M. A. (1992) Cancer Res. 52, 1770-1774
40. Sahovic, E. A., Colvin, M., Hilton, J., and Ogawa, M. (1988) Cancer Res. 48, 1223-1226
41. Bunting, K. D., and Townsend, A. J. (1996) J. Biol. Chem. 271, 11891-11896